Product NDC: | 0071-0527 |
Proprietary Name: | Accupril |
Non Proprietary Name: | QUINAPRIL HYDROCHLORIDE |
Active Ingredient(s): | 5 mg/1 & nbsp; QUINAPRIL HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0071-0527 |
Labeler Name: | Parke-Davis Div of Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019885 |
Marketing Category: | NDA |
Start Marketing Date: | 19911119 |
Package NDC: | 0071-0527-40 |
Package Description: | 100 BLISTER PACK in 1 CARTON (0071-0527-40) > 1 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 0071-0527-40 |
Proprietary Name | Accupril |
Package Description | 100 BLISTER PACK in 1 CARTON (0071-0527-40) > 1 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 0071-0527 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | QUINAPRIL HYDROCHLORIDE |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19911119 |
Marketing Category Name | NDA |
Labeler Name | Parke-Davis Div of Pfizer Inc |
Substance Name | QUINAPRIL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |